| Secondary |
| Prophylaxis |
16.0% |
| Non-small Cell Lung Cancer |
11.4% |
| Non-small Cell Lung Cancer Stage Iii |
9.9% |
| Product Used For Unknown Indication |
6.7% |
| T-cell Type Acute Leukaemia |
5.4% |
| Neoplasm Malignant |
5.1% |
| Anxiety |
4.7% |
| Drug Use For Unknown Indication |
4.6% |
| Schizophrenia |
4.3% |
| Pain |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Depression |
3.8% |
| Glioblastoma |
2.7% |
| Head And Neck Cancer |
2.7% |
| Bipolar Disorder |
2.6% |
| Breast Cancer |
2.5% |
| Supplementation Therapy |
2.4% |
| Nausea |
2.3% |
| Squamous Cell Carcinoma |
2.3% |
| Oesophageal Carcinoma |
2.2% |
|
| Vomiting |
13.3% |
| Dyspnoea |
6.9% |
| Oesophagitis |
6.9% |
| Pneumonia |
6.4% |
| Sepsis |
6.4% |
| Thrombocytopenia |
6.4% |
| White Blood Cell Count Decreased |
6.0% |
| Weight Decreased |
5.5% |
| Pyrexia |
5.0% |
| Radiation Oesophagitis |
4.6% |
| Respiratory Failure |
4.1% |
| Weight Increased |
4.1% |
| Neutropenia |
3.7% |
| Abdominal Pain |
3.2% |
| Dehydration |
3.2% |
| Haematemesis |
3.2% |
| Dizziness |
2.8% |
| Hallucination, Visual |
2.8% |
| Headache |
2.8% |
| Intentional Drug Misuse |
2.8% |
|
| Concomitant |
| Breast Cancer |
24.1% |
| Metastases To Bone |
12.2% |
| Pain |
10.0% |
| T-cell Type Acute Leukaemia |
6.8% |
| Neoplasm Malignant |
5.4% |
| Prophylaxis |
4.9% |
| Drug Use For Unknown Indication |
4.2% |
| Non-small Cell Lung Cancer |
3.5% |
| Breakthrough Pain |
3.4% |
| Depression |
3.2% |
| Hypertension |
3.1% |
| Product Used For Unknown Indication |
2.8% |
| Non-hodgkin's Lymphoma |
2.8% |
| Glioblastoma Multiforme |
2.5% |
| Arthritis |
2.0% |
| Bone Pain |
2.0% |
| Multiple Myeloma |
1.9% |
| Nausea |
1.8% |
| Breast Cancer Metastatic |
1.7% |
| Hormone Replacement Therapy |
1.7% |
|
| Weight Decreased |
17.0% |
| Vomiting |
13.8% |
| Vision Blurred |
9.2% |
| White Blood Cell Count Decreased |
7.1% |
| Weight Increased |
5.3% |
| Wound Treatment |
4.6% |
| Tooth Infection |
4.2% |
| Tooth Fracture |
3.9% |
| Wound Infection |
3.9% |
| Spinal Osteoarthritis |
3.5% |
| Toothache |
3.2% |
| Visual Acuity Reduced |
3.2% |
| Rash |
2.8% |
| Therapeutic Response Unexpected |
2.8% |
| Tooth Extraction |
2.8% |
| Tooth Loss |
2.8% |
| Fatigue |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Neoplasm Malignant |
2.5% |
| Radiation Oesophagitis |
2.5% |
|
